GREGORY BLANKENSHIP: Open Payments
NPI 1942846365 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,839 in 225 payments from 17 companies in 2025. Trend: 2023 $3,062 · 2024 $2,768 · 2025 $3,839
Food & beverage: $3,740Education: $100
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 34 | $815 |
| E.R. Squibb & Sons, L.L.C. | 32 | $574 |
| Otsuka America Pharmaceutical, Inc. | 27 | $458 |
| ABBVIE INC. | 39 | $453 |
| Teva Pharmaceuticals USA, Inc. | 16 | $311 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $310 |
| Neurocrine BioSciences, Inc. | 11 | $221 |
| Lundbeck LLC | 15 | $200 |
| Janssen Pharmaceuticals, Inc | 7 | $123 |
| Axsome Therapeutics, Inc. | 4 | $83 |
Products named: COBENFY, HETLIOZ, VRAYLAR, REXULTI, CAPLYTA, FANAPT, INGREZZA, UZEDY.
Industry payments across OH — which companies pay providers there.
